Gáll, Z.; Kelemen, K.; Tolokán, A.; Zolcseak, I.; Sável, I.; Bod, R.; Ferencz, E.; Vancea, S.; Urkon, M.; Kolcsár, M.
Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy. Biomedicines 2022, 10, 1811.
https://doi.org/10.3390/biomedicines10081811
AMA Style
Gáll Z, Kelemen K, Tolokán A, Zolcseak I, Sável I, Bod R, Ferencz E, Vancea S, Urkon M, Kolcsár M.
Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy. Biomedicines. 2022; 10(8):1811.
https://doi.org/10.3390/biomedicines10081811
Chicago/Turabian Style
Gáll, Zsolt, Krisztina Kelemen, Andrea Tolokán, István Zolcseak, István Sável, Réka Bod, Elek Ferencz, Szende Vancea, Melinda Urkon, and Melinda Kolcsár.
2022. "Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy" Biomedicines 10, no. 8: 1811.
https://doi.org/10.3390/biomedicines10081811
APA Style
Gáll, Z., Kelemen, K., Tolokán, A., Zolcseak, I., Sável, I., Bod, R., Ferencz, E., Vancea, S., Urkon, M., & Kolcsár, M.
(2022). Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy. Biomedicines, 10(8), 1811.
https://doi.org/10.3390/biomedicines10081811